bioMérieux Triples Footprint in Philadelphia with 32,000 sq. ft. State-Of-The-Art Predictive Diagnostics Innovation Center

Site Marks Company’s Continued Investment in xPRO™ Program Offering Custom, Cutting-Edge, Molecular Diagnostic Testing Solutions in a Fraction of the Time PHILADELPHIA, May 16, 2023 /PRNewswire/ — bioMérieux, a world leader in in vitro diagnostics, has announced the lease signing of a new, 32,000 sq. ft. state-of-the-art molecular innovation center at the Navy Yard in … Read more